Skip to content
Home/Companies/Biotech/BioGenes
BioGenes

BioGenes

Biotech·Germany·Exited 2015·Held 12yr
Entry
2003
Hold
12yr
Exit
2015

Who owns BioGenes?

BioGenes was owned by IBB Ventures through VC Fonds Technologie Berlin (1997 vintage) from 2003 to 2015, exited via Secondary.

Hand-verified · updated 2026-08-10

IBB Ventures
Investor
IBB Ventures
VC Fonds Technologie Berlin · 1997 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Websitebiogenes.de
Exit Type
Secondary
Buyer
–
MOIC
–
Exit Year
2015

More from VC Fonds Technologie Berlin

Other portfolio companies in the same fund.

Bounti
Bounti
Active
SoftwareGermany· 2026
hellomed
Active
HealthTechGermany· 2026
Level Nine
Active
ClimateTechGermany· 2026
Nox Mobility
Nox Mobility
Active
MobilityGermany· 2026
Remi Health
Remi Health
Active
HealthTechGermany· 2026
Amara
Active
HealthTechGermany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track BioGenes

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on BioGenes.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue